Next Article in Journal
Effect of Hard- and Soft-Density Insoles on the Postural Control of Adults over 65 Years of Age: A Cross over Clinical Trial
Previous Article in Journal
A Hybrid Transformer-Convolutional Neural Network for Segmentation of Intracerebral Hemorrhage and Perihematomal Edema on Non-Contrast Head Computed Tomography (CT) with Uncertainty Quantification to Improve Confidence
Previous Article in Special Issue
A Semi-Three-Dimensional Bioprinted Neurocardiac System for Tissue Engineering of a Cardiac Autonomic Nervous System Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Advances in Organoid Research and Developmental Engineering

by
Peter V. Hauser
1,2
1
Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA
2
Medical and Research Services, Greater Los Angeles Veterans Affairs Healthcare System at Sepulveda, North Hills, CA 91344, USA
Bioengineering 2024, 11(12), 1275; https://doi.org/10.3390/bioengineering11121275
Submission received: 10 December 2024 / Accepted: 12 December 2024 / Published: 15 December 2024
(This article belongs to the Special Issue Advances in Organoid Research and Developmental Engineering)
Over the last decade, organoid research has emerged as a transformative field in biomedical science, offering unparalleled opportunities in disease modeling, pharmacological testing, and tissue engineering. The number of research articles published in the field has increased exponentially from 189 in 2014 to 3899 in 2024. This Special Issue of Bioengineering highlights studies showcasing advances in organoid research.
The Special Issue opens with a comprehensive review of organoid imaging technologies by Fei et al., emphasizing state-of-the-art approaches like light-sheet microscopy and multi-photon imaging for tracking organoid development at a cellular resolution [1]. The authors suggest that in order to enhance organoid-based drug discovery and disease modeling efforts, integrated imaging platforms for whole-object 3D imaging are necessary to enable non-invasive organoid monitoring and evaluation.
The effects of α2-adrenergic agonist brimonidine in glaucoma disease modeling are the subject of two studies by the Ohguro group. Watanabe et al. describe how the α2-adrenergic agonist brimonidine mitigates TGF-β2-induced fibrosis-related changes in a 2D and 3D in vitro model that replicates the effect of glaucoma on the human trabecular network [2]. It appears that brimonidine reduces the barrier function in trabecular cell monolayers and reduces the stiffness in 3D spheroids. On the other hand, Umetsu et al. demonstrate that brimonidine significantly modulates the adipogenic effects induced by ROCK inhibitors, particularly ripasudil, by suppressing lipid accumulation and changes in extracellular matrix components in differentiated adipocytes [3]. Both studies suggest a potential therapeutic application of brimonidine in glaucoma treatment. The quest to find chemical cues that drive retinoic acid-induced remodeling in human conjunctival fibroblasts is addressed by Tsugeno et al. [4]. Their findings elucidate how retinoic acid influences extracellular matrix dynamics in 2D and 3D cultured human conjunctival fibroblasts, offering critical insights for tissue regeneration strategies.
Karakaidos et al. compare the genotoxic effects of UV- and visible light-based bioprinting [5]. By assessing DNA damage, the authors propose bioprinting protocols that balance cell viability with reduced genotoxic risks, advancing tissue engineering applications. An interesting study by Sánchez-Salazar et al. presents a 3D-printed tumor-on-chip platform for colorectal cancer research [6]. They demonstrate how microsphere cultures in the chip enable precise drug testing while replicating in vivo-like environments, making strides toward more effective and personalized cancer treatments. In the realm of organ development, Hamon et al. explore how oxygen levels and the initial absence of tissue vascularization influence kidney organoid branching [7]. Their work highlights the critical role of hypoxia in modulating cellular subpopulations, providing a platform for understanding kidney morphogenesis and potential regenerative therapies. Finally, Hernandez et al. present a semi-3D bioprinted neurocardiac model that integrates cardiac and neuronal tissues [8]. Their innovative design demonstrates functional neuro-cardiac coupling, creating a robust platform for studying the cardiac autonomic nervous system under healthy and diseased conditions.
Collectively, these studies exemplify the innovative strides being made in organoid research. As organoid technologies advance, the integration of organoid models with integrated analysis platforms and artificial intelligence will be crucial for driving translational research and therapeutic applications. This Special Issue highlights efforts to shape the future of regenerative medicine, precision therapeutics, and organoid-based disease modeling.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Fei, K.; Zhang, J.; Yuan, J.; Xiao, P. Present Application and Perspectives of Organoid Imaging Technology. Bioengineering 2022, 9, 121. [Google Scholar] [CrossRef] [PubMed]
  2. Watanabe, M.; Sato, T.; Tsugeno, Y.; Higashide, M.; Furuhashi, M.; Umetsu, A.; Suzuki, S.; Ida, Y.; Hikage, F.; Ohguro, H. An α2-Adrenergic Agonist, Brimonidine, Beneficially Affects the TGF-β2-Treated Cellular Properties in an In Vitro Culture Model. Bioengineering 2022, 9, 310. [Google Scholar] [CrossRef] [PubMed]
  3. Umetsu, A.; Ida, Y.; Sato, T.; Watanabe, M.; Tsugeno, Y.; Furuhashi, M.; Hikage, F.; Ohguro, H. Brimonidine Modulates the ROCK1 Signaling Effects on Adipogenic Differentiation in 2D and 3D 3T3-L1 Cells. Bioengineering 2022, 9, 327. [Google Scholar] [CrossRef] [PubMed]
  4. Tsugeno, Y.; Sato, T.; Watanabe, M.; Higashide, M.; Furuhashi, M.; Umetsu, A.; Suzuki, S.; Ida, Y.; Hikage, F.; Ohguro, H. All Trans-Retinoic Acids Facilitate the Remodeling of 2D and 3D Cultured Human Conjunctival Fibroblasts. Bioengineering 2022, 9, 463. [Google Scholar] [CrossRef] [PubMed]
  5. Karakaidos, P.; Kryou, C.; Simigdala, N.; Klinakis, A.; Zergioti, I. Laser Bioprinting of Cells Using UV and Visible Wavelengths: A Comparative DNA Damage Study. Bioengineering 2022, 9, 378. [Google Scholar] [CrossRef] [PubMed]
  6. Sánchez-Salazar, M.G.; Crespo-López Oliver, R.; Ramos-Meizoso, S.; Jerezano-Flores, V.S.; Gallegos-Martínez, S.; Bolívar-Monsalve, E.J.; Ceballos-González, C.F.; Trujillo-de Santiago, G.; Álvarez, M.M. 3D-Printed Tumor-on-Chip for the Culture of Colorectal Cancer Microspheres: Mass Transport Characterization and Anti-Cancer Drug Assays. Bioengineering 2023, 10, 554. [Google Scholar] [CrossRef] [PubMed]
  7. Hamon, M.; Cheng, H.-M.; Johnson, M.; Yanagawa, N.; Hauser, P.V. Effect of Hypoxia on Branching Characteristics and Cell Subpopulations during Kidney Organ Culture. Bioengineering 2022, 9, 801. [Google Scholar] [CrossRef] [PubMed]
  8. Hernandez, I.; Ramirez, S.P.; Salazar, W.V.; Mendivil, S.; Guevara, A.; Patel, A.; Loyola, C.D.; Dorado, Z.N.; Joddar, B. A Semi-Three-Dimensional Bioprinted Neurocardiac System for Tissue Engineering of a Cardiac Autonomic Nervous System Model. Bioengineering 2023, 10, 834. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hauser, P.V. Advances in Organoid Research and Developmental Engineering. Bioengineering 2024, 11, 1275. https://doi.org/10.3390/bioengineering11121275

AMA Style

Hauser PV. Advances in Organoid Research and Developmental Engineering. Bioengineering. 2024; 11(12):1275. https://doi.org/10.3390/bioengineering11121275

Chicago/Turabian Style

Hauser, Peter V. 2024. "Advances in Organoid Research and Developmental Engineering" Bioengineering 11, no. 12: 1275. https://doi.org/10.3390/bioengineering11121275

APA Style

Hauser, P. V. (2024). Advances in Organoid Research and Developmental Engineering. Bioengineering, 11(12), 1275. https://doi.org/10.3390/bioengineering11121275

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop